Sign in

What researchers published on Narcolepsy

1,861 papers, newest first.

Showing 100 of 1,861

  • MRI-based volume assessments show no changes in hippocampus, amygdala, thalamus and brainstem subregions in narcolepsy type 1.Sleep medicine
  • ReviewOrexin-2 Receptor Agonists in Narcolepsy: Restoring the Missing Signal.Journal of clinical medicine
  • Orgasmolepsy in narcolepsy type 1: delayed disclosure and incomplete response to pitolisant requiring combination therapy.Acta neurologica Belgica
  • Phenotype-specific differences in mortality and cerebrovascular risk in narcolepsy type 1 and type 2: a real-world propensity score-matched cohort study.Annals of medicine and surgery (2012)
  • Long-term efficacy, safety, and patient-reported outcomes of oveporexton in adults with narcolepsy type 1.Annals of medicine and surgery (2012)
  • Diagnosis and Symptoms of Narcolepsy from the Patient Perspective: Results from In-Depth Qualitative Interviews.CNS spectrums
  • Solriamfetol for Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea: Effect Sizes and Numbers Needed to Treat or Harm.CNS spectrums
  • 2010 and 2013 Incidence Peaks in Narcolepsy and Idiopathic Hypersomnia Linked to Type A H1N1 and Type B Victoria Influenza Strains.Journal of sleep research
  • Meta-analysisEfficacy and safety of selective orexin 2 receptor agonists in narcolepsy type 1: a systematic review and meta-analysis of randomized controlled trials.Journal of neurology
  • Absence of Markers of Inflammation in Blood and Cerebrospinal Fluid in Routine Analysis of Adult and Paediatric Narcolepsy Type 1.Journal of sleep research
  • A prospective longitudinal study of depressive symptoms in adolescents with narcolepsy: Excessive daytime sleepiness as a key correlate.Sleep medicine
  • Poor Test-Retest Stability of Nocturnal REM Sleep Onset Markers in Narcolepsy Type 1.Sleep
  • ReviewArtificial Intelligence Applied to Nocturnal and Daytime Neurophysiology and Actigraphy in Central Disorders of Hypersomnolence.Sleep medicine clinics
  • Meta-analysisPrevalence of Sleep Disorders in Patients With Knee, Hip, and Hand Osteoarthritis: A Systematic Review With Meta-Analysis.The Journal of orthopaedic and sports physical therapy
  • Trial resultPsychometric properties of the novel patient-reported Functional Impacts of Narcolepsy Instrument (FINI) using data from phase 3 clinical trials in narcolepsy type 1.Frontiers in neurology
  • ReviewOrexin deficiency and cardiometabolic risk in narcolepsy: mechanistic pathways and therapeutic implications.Function (Oxford, England)
  • Modified sleep stage sequence analysis based on the stage immediately preceding each REM sleep period during nocturnal polysomnography to identify candidates for narcolepsy workup.Sleep medicine
  • The effectiveness and value of oveporexton for narcolepsy.Journal of managed care & specialty pharmacy
  • ReviewSex- and gender-related differences in narcolepsy and idiopathic hypersomnia: a narrative review.Sleep medicine reviews
  • ReviewThe role of histamine in narcolepsy type 1: a narrative review.Frontiers in neurology
  • Case reportCase Report: Narcolepsy associated with anti-Ma2 antibody positivity.Frontiers in immunology
  • Daytime naps as digital endpoints in narcolepsy.Sleep
  • Trial resultSymptom improvement with dosing above 9 g of low-sodium oxybate: effectiveness and safety in participants with narcolepsy in the DUET study.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
  • ReviewChronic pain in narcolepsy reflects interacting neurobiological and psychological mechanisms: a mini-review.Frontiers in sleep
  • Post-Nap Sleep Inertia in Narcolepsy Type 1 and Idiopathic Hypersomnia.Sleep
  • Narcolepsy and Idiopathic Hypersomnia Real-World Treatment Patterns and Changes in Alerting Agent Use After Low-Sodium Oxybate Initiation: A Retrospective Claims Analysis.Neurology and therapy
  • The sleep EEG spectral profile of narcolepsy with comorbid obstructive sleep apnea more closely resembles narcolepsy than obstructive sleep apnea.Sleep medicine
  • Meta-analysisSodium oxybate for excessive daytime sleepiness in narcolepsy: a systematic review and meta-analysis of randomized placebo-controlled trials.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
  • Incidence, healthcare resource use, and costs of narcolepsy: a French claims database analysis.Sleep medicine
  • ReviewWhat can narcolepsy teach us about hypocretin and dementia?Ageing research reviews
  • A retrospective exploratory study of sleep spindles as an adjunctive diagnostic marker for narcolepsy type 1: a comparison with insufficient sleep syndrome.Sleep and biological rhythms
  • ReviewCytokines in narcolepsy type 1: pathogenic relevance, biomarker potential, and future directions.Frontiers in neurology
  • Case reportAirway Rescue and Extended Recovery in Prone Nonintubated Anesthesia: A Narcolepsy Type 2 Case Report.Cureus
  • A New Electrophysiological Approach to Sleep Microstructure: The Gülhane Classification of K-Complex Subtypes in Narcolepsy Type 1 and Type 2.Life (Basel, Switzerland)
  • The German version of the Sleep Inertia Questionnaire in central disorders of hypersomnolence: a validation study.Sleep medicine
  • Development and Preliminary Evaluation of the Wilder-Addison Narcolepsy Function Scale for Occupational Performance.OTJR : occupation, participation and health
  • Narcolepsy-like presentations in intellectual disability with comorbid epilepsy and obstructive sleep apnea: a case-based diagnostic analysis and literature-informed discussion.Frontiers in psychiatry
  • Case reportFunctional (Dissociative) Narcolepsy: A Case Report and Literature Review.Cureus
  • Sleep-disordered breathing and psychiatric comorbidities in narcolepsy: A 10-year retrospective study from Saudi Arabia.Sleep medicine: X
  • Case reportRapid Eye Movement (REM)-Predominant Obstructive Sleep Apnea (OSA) Coexisting With and Initially Obscuring Narcolepsy Type 1: A Nine-Year Longitudinal Case Report.Cureus
  • ReviewCognitive function in central disorders of hypersomnolence.Progress in brain research
  • Analytical evaluation and method comparison of an orexin-A radioimmunoassay in cerebrospinal fluid: establishing a cut-off value for type 1 narcolepsy and exploring genetic and clinical characteristics.Sleep medicine
  • Candidate biomarkers in narcolepsy in H1N1-vaccinated cohorts: A proteomic and transcriptomic study.Sleep medicine
  • Social determinants of health, clinical outcomes, and healthcare resource utilization in participants with and without narcolepsy in the All of Us research program.Sleep advances : a journal of the Sleep Research Society
  • Delayed Diagnosis of Narcolepsy: Family History and Clinical Features as Predictive Factors.Psychiatry investigation
  • To sleep and dream: Unraveling narcolepsy.Proceedings of the National Academy of Sciences of the United States of America
  • How the Albert Lasker Winners Identified Orexin and Elucidated the Peptide's Role in Narcolepsy.JAMA
  • Randomised trialOveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.The New England journal of medicine
  • The Legacy of Orexin (Hypocretin) Research in Narcolepsy and Beyond.The New England journal of medicine
  • Narcolepsy.JAMA
  • Ventilatory control in young patients with narcolepsy type 1: A case-control study.Sleep medicine
  • Targeted Treatment for Narcolepsy Type 1.The New England journal of medicine
  • The Orexin System-A Key Component of Sleep Regulatory Networks and Involvement in Narcolepsy: The 2026 Albert Lasker Basic Medical Research Award.JAMA
  • Mignot and Yanagisawa win Lasker prize for discovery of the role of orexins in wake, sleep, and narcolepsy.The Journal of clinical investigation
  • ReviewOrexin pathway modulation in narcolepsy: from Autoimmune mechanisms to nanotechnology enabled therapeutic delivery.Sleep medicine
  • ReviewAssessing mortality risk in narcolepsy: Evidence from population studies.PCN reports : psychiatry and clinical neurosciences
  • Rapid Eye Movement Sleep-Related Indicators with Promising Performance in Diagnosing Narcolepsy.Nature and science of sleep
  • A distinct psychotic phenotype in pediatric narcolepsy type 1: a case-control study.Sleep medicine
  • Case reportTherapeutic Prospects of Ketamine for Cataplexy in Narcolepsy Type 1: Evidence from a Human Case and a Murine Model.Annals of neurology
  • Wilson's Disease Coexisting with Narcolepsy Type 1: Evidence for a Multifactorial Cause of Excessive Daytime Sleepiness from a Case Report.Neurology and therapy
  • ReviewThe impact of narcolepsy and idiopathic hypersomnia on work-related outcomes: a systematic literature review.Sleep advances : a journal of the Sleep Research Society
  • Medication Treatment Modulates Sleep Architecture and Cognitive-Related Cortical Hemodynamics in Narcolepsy Type 1.Nature and science of sleep
  • Randomised trialSafety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial.The Lancet. Neurology
  • Targeting orexin signalling in narcolepsy.The Lancet. Neurology
  • Sex differences in patients with narcolepsy type 1: Clinical manifestations, sleep profiles, and symptoms evolution.Sleep medicine
  • Observational studyThe SOMNUS study: Real-world burden of narcolepsy in Spanish adults.Sleep medicine
  • Briefing Chat: New narcolepsy drug could unlock host of novel brain therapies.Nature
  • Case reportDevelopment of Narcolepsy Type 1 Following COVID-19 Infection in a Patient Previously Diagnosed With Idiopathic Hypersomnia: A Case Report.Cureus
  • Case reportSleep-related eating disorder after dose escalation of sodium oxybate in narcolepsy type 1.Journal of Taibah University Medical Sciences
  • Novel Compounds as Orexin 2 Receptor Agonists for Treating Narcolepsy.ACS medicinal chemistry letters
  • Daily briefing: Narcolepsy drug could kick off an Ozempic-style moment for the brain.Nature
  • ReviewOveporexton: The first-in-class orexin receptor 2 (OX2R) agonist approved for treatment of narcolepsy type 1 (NT1).Drug discoveries & therapeutics
  • First-of-its-kind narcolepsy drug opens door to new therapies for the brain.Nature
  • An actigraphy-based algorithm to assess daytime napping in people with narcolepsy type 1.Sleep
  • Risk of Hypertension and Mortality Among People With Narcolepsy or Idiopathic Hypersomnia: A Retrospective Cohort Analysis of the Danish National Patient Registry.Journal of sleep research
  • Immunocyte phenotypes underlying the causal autoimmune features in narcolepsy type 1.Journal of thoracic disease
  • Randomised trialDefining a Clinically Meaningful Within-Person Change Threshold for the Psychomotor Vigilance Test in Narcolepsy Type 1.Therapeutic innovation & regulatory science
  • Orexin receptor agonist secures landmark narcolepsy approval.Nature reviews. Drug discovery
  • Correction to: Narcolepsy and risk of cardiovascular outcomes beyond stimulant use.Sleep
  • Telemedicine Consultation as Diagnostic Triage for Adult and Children With Suspected Narcolepsy: A Reliability and Diagnostic Accuracy Study.Journal of sleep research
  • Targeting Orexin 2 Receptors in Idiopathic Hypersomnia and Narcolepsy: A Randomised Phase 1b Proof-Of-Concept Study of Alixorexton.Journal of sleep research
  • Global and Partial Cataplexy, Geste Antagoniste, and Startle Response in Narcolepsy Type 1.JAMA neurology
  • Case reportHypersomnia.Continuum (Minneapolis, Minn.)
  • Case reportNarcolepsy-like pathologic daytime sleepiness in a patient with obsessive-compulsive disorder and attention deficit hyperactivity disorder: a Case Report.Frontiers in sleep
  • ReviewTherapeutic potential of targeting the orexin (hypocretin) system in sleep disorders.Nature reviews. Endocrinology
  • Differences in Sleep Spindle Characteristics Between Children With Narcolepsy and Those With Other Causes of Subjective Sleepiness.Journal of sleep research
  • Hidden burden and economic vulnerability of Narcolepsy Patients - Accessibility as the major challenge for a new therapeutic era.Sleep medicine
  • Reply to "Unexpectedly higher mortality in non‑type 1 narcolepsy: diagnostic heterogeneity or unmeasured confounders?".Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
  • 'I had to change my way of thinking, change my emotions, and learn how to react': A narrative study on the management of narcolepsy symptoms and coping with the disease from patients' perspectives.Sleep medicine
  • Oxytocin in the amygdala links social and reward signals to cataplexy in mice.Nature neuroscience
  • Oxytocin promotes socially triggered cataplexy.Nature neuroscience
  • From radioimmunoassay to mass spectrometry: redefining hypocretin/orexin measurement in narcolepsy.Sleep
  • Reply to "The question of whether narcolepsy increases mortality should be answered based on reliable studies".Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
  • Reply to "Veteran status as an underappreciated confound in narcolepsy mortality".Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
  • ReviewNarcolepsy: immunity, neural circuitry, and brain network reconfiguration.Frontiers in immunology
  • GABA neurons in the sublaterodorsal tegmental nucleus suppress wakefulness in healthy and narcoleptic mice.PLoS biology
  • Nocturnal features and daytime characteristics in narcolepsy: reliability and diagnostic relevance for NT1 Versus NT2.Sleep
  • [Analysis of clinical characteristics and risk factors in children and adolescents with narcolepsy type 1 across different severities of daytime sleepiness].Zhonghua yi xue za zhi
  • PreprintAntibodies against influenza A/H1N1pdm2009 and B/Victoria strains but not A/H3N2 are increased in recent onset type 1 narcolepsy versus matched controls.medRxiv : the preprint server for health sciences
  • Case reportNarcolepsy with co-occurring epilepsy: diagnostic pitfalls and management strategy.Therapeutic advances in neurological disorders